What's in LigaChem Biosciences, Inc.'s pipeline?

LigaChem Biosciences, Inc. has 10 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 7 in Phase 2, 3 in Phase 1.

Which companies overlap with LigaChem Biosciences, Inc.'s portfolio?

Top competitors by shared drug class: All India Institute of Medical Sciences, Assistance Publique - Hôpitaux de Paris, Nantes University Hospital, National Institute of Allergy and Infectious Diseases (NIAID), The Aurum Institute NPC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ligachem-biosciences-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

LigaChem Biosciences, Inc. — Portfolio Competitive Intelligence Brief

LigaChem Biosciences, Inc. pipeline: 0 marketed, 0 filed, 0 Phase 3, 7 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 7 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Infectious Disease · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

All India Institute of Medical Sciences · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Nantes University Hospital · 1 shared drug class
National Institute of Allergy and Infectious Diseases (NIAID) · 1 shared drug class
The Aurum Institute NPC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for LigaChem Biosciences, Inc.:

Cite this brief

Drug Landscape (2026). LigaChem Biosciences, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ligachem-biosciences-inc. Accessed 2026-05-16.